Back to Search Start Over

Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS

Authors :
Gillian I. Rice
Patrick Revy
Yanick J. Crow
Russell C. Dale
Mathieu P Rodero
Nicolas Manel
Darragh Duffy
Mathieu Maurin
Florence Petit
Cécile Conrad
Elias Bou Samra
Matthieu Gratia
Mounira Amor-Guéret
Immunité et cancer (U932)
Université Paris Descartes - Paris 5 (UPD5)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Stress génotoxiques et cancer
Université Paris-Sud - Paris 11 (UP11)-Institut Curie [Paris]-Centre National de la Recherche Scientifique (CNRS)
Laboratory of neurogenetics and neuroinflammation (Equipe Inserm U1163)
Imagine - Institut des maladies génétiques (IMAGINE - U1163)
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
University of Manchester [Manchester]
Immunobiologie des Cellules dendritiques
Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Hôpital Jeanne de Flandres
Université de Lille, Droit et Santé-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
The University of Sydney
University of Edinburgh
This work was supported by Laboratoire d'Excellence Vaccine Research Institute (ANR-10-LABX-77), Laboratoire d'Excellence Biologie des Cellules Dendritiques (ANR-10-IDEX-0001-02 PSL* and ANR-11-LABX-0043), ACTERIA Foundation, Fondation Schlumberger pour l'Education et la Recherche, Agence Nationale de Recherche sur le Sida et les hépatites virales (ECTZ25472 and ECTZ36691), Sidaction (VIH2016126002), Bristol-Myers Squibb Foundation, European Research Council (grant 309848 HIVINNATE and INSERM) to N. Manel, National Research Agency (ANR-14-CE14-0004) and Institut Curie to N. Manel and M. Amor-Gueret, Institut National du Cancer (2016-1-PLBIO-03-ICR-1), Ligue Nationale Contre le Cancer (Comité de l’Essonne), and Centre National de la Recherche Scientifique to M. Amor-Gueret. Y.J. Crow acknowledges the European Research Council (GA 309449 and 786142 - E-T1IFNs), ERA-NET Neuron (MR/M501803/1), and a state subsidy managed by the National Research Agency (France) under the 'Investments for the Future' program bearing the reference ANR-10-IAHU-01. Y.J. Crow and D. Duffy acknowledge the National Research Agency (grant CE17001002)
We thank Philippe Benaroch for critical reading of the manuscript
Vincent Bondet for the Simoa analysis
Santy Marques-Ladeira for bioinformatics analysis
Xavier Lahaye for molecular biology
Géraldine Buhagiar-Labarchède and Rosine Onclercq-Delic for technical assistance
Aude Vieillefon, Audrey Rapinat, and David Gentien from the Genomics Platform of the translational research department of Institut Curie
and Prof. Dominique Stoppa-Lyonnet, Head of the Department of Genetics at Institut Curie and Professor of Medical Genetics at University Paris Descartes, for stimulating discussions. Y.J. Crow and D. Duffy thank ImmunoQure AG for sharing of antibodies used to assess interferon alpha protein levels in the Simoa assay.
ANR-10-LABX-0077,VRI,Initiative for the creation of a Vaccine Research Institute(2010)
ANR-10-IDEX-0001,PSL,Paris Sciences et Lettres(2010)
ANR-14-CE14-0004,INNATENUCLEOTIDES,Un nouveau modèle de régulation de la réponse immunitaire innée par le métabolisme des nucléotides(2014)
ANR-10-IAHU-0001,Imagine,Institut Hospitalo-Universitaire Imagine(2010)
ANR-16-CE17-0010,IFNX,Investigation des interferonopathies type I humaine(2016)
European Project: 309848,EC:FP7:ERC,ERC-2012-StG_20111109,HIVINNATE(2013)
European Project: 309449,EC:FP7:ERC,ERC-2012-StG_20111109,T1-IFN(2013)
Vougny, Marie-Christine
Laboratoires d'excellence - Initiative for the creation of a Vaccine Research Institute - - VRI2010 - ANR-10-LABX-0077 - LABX - VALID
Initiative d'excellence - Paris Sciences et Lettres - - PSL2010 - ANR-10-IDEX-0001 - IDEX - VALID
Appel à projets générique - Un nouveau modèle de régulation de la réponse immunitaire innée par le métabolisme des nucléotides - - INNATENUCLEOTIDES2014 - ANR-14-CE14-0004 - Appel à projets générique - VALID
Instituts Hospitalo-Universitaires - Institut Hospitalo-Universitaire Imagine - - Imagine2010 - ANR-10-IAHU-0001 - IAHU - VALID
Investigation des interferonopathies type I humaine - - IFNX2016 - ANR-16-CE17-0010 - AAPG2016 - VALID
Innate sensing of HIV and immune responses - HIVINNATE - - EC:FP7:ERC2013-01-01 - 2017-12-31 - 309848 - VALID
Definition and characterization of type I interferonopathies - T1-IFN - - EC:FP7:ERC2013-03-01 - 2018-02-28 - 309449 - VALID
Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur [Paris]
Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques (LCBPT - UMR 8601)
Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Curie [Paris]-Université Paris Descartes - Paris 5 (UPD5)
Modélisation et Immunologie pour la Thérapie (CBMIT)
Université Paris Descartes - Paris 5 (UPD5)
Centre National de la Recherche Scientifique (CNRS)-Institut Curie [Paris]-Université Paris-Sud - Paris 11 (UP11)
Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Developpement Normal et Pathologique du Système Immunitaire
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Laboratoire de dynamique des systèmes neuroendocriniens
Institut National de la Santé et de la Recherche Médicale (INSERM)
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Université Paris Descartes - Paris 5 (UPD5)-Institut Curie-Institut National de la Santé et de la Recherche Médicale (INSERM)
Université Paris-Sud - Paris 11 (UP11)-Institut Curie-Centre National de la Recherche Scientifique (CNRS)
Source :
The Journal of Experimental Medicine, Journal of Experimental Medicine, Journal of Experimental Medicine, 2019, 216 (5), pp.jem.20181329. ⟨10.1084/jem.20181329⟩, Journal of Experimental Medicine, Rockefeller University Press, 2019, 216 (5), pp.jem.20181329. ⟨10.1084/jem.20181329⟩, Journal of Experimental Medicine, Rockefeller University Press, 2019, 216 (5), pp.1199-1213. ⟨10.1084/JEM.20181329⟩, Gratia, M, Rodero, M P, Conrad, C, Bou Samra, E, Maurin, M, Rice, G I, Duffy, D, Revy, P, Petit, F, Dale, R C, Crow, Y J, Amor-Gueret, M & Manel, N 2019, ' Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS ', The Journal of experimental medicine . https://doi.org/10.1084/jem.20181329, Journal of Experimental Medicine, Rockefeller University Press, 2019, 216 (5), pp.1199-1213. ⟨10.1084/jem.20181329⟩
Publication Year :
2018

Abstract

How self-DNA avoids unchecked activation of innate DNA sensors is poorly understood. Gratia et al. show that BLM protein, mutated in Bloom syndrome (BS), restrains interferon-stimulated gene induction and micronuclei recognition by cGAS. Consistently, BS patients exhibit an interferon signature.<br />Cellular innate immune sensors of DNA are essential for host defense against invading pathogens. However, the presence of self-DNA inside cells poses a risk of triggering unchecked immune responses. The mechanisms limiting induction of inflammation by self-DNA are poorly understood. BLM RecQ–like helicase is essential for genome integrity and is deficient in Bloom syndrome (BS), a rare genetic disease characterized by genome instability, accumulation of micronuclei, susceptibility to cancer, and immunodeficiency. Here, we show that BLM-deficient fibroblasts show constitutive up-regulation of inflammatory interferon-stimulated gene (ISG) expression, which is mediated by the cGAS–STING–IRF3 cytosolic DNA–sensing pathway. Increased DNA damage or down-regulation of the cytoplasmic exonuclease TREX1 enhances ISG expression in BLM-deficient fibroblasts. cGAS-containing cytoplasmic micronuclei are increased in BS cells. Finally, BS patients demonstrate elevated ISG expression in peripheral blood. These results reveal that BLM limits ISG induction, thus connecting DNA damage to cellular innate immune response, which may contribute to human pathogenesis.

Details

ISSN :
15409538 and 00221007
Volume :
216
Issue :
5
Database :
OpenAIRE
Journal :
The Journal of experimental medicine
Accession number :
edsair.doi.dedup.....1eb266232e4eab8d6e727841eb7c709f